Results: 407

Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials

Lancet; 355 (9219), 2000
Two randomised controlled trials of sexually transmitted disease (STD) treatment for the prevention of HIV-1 infection; in Mwanza; Tanzania and Rakai; Uganda; unexpectedly produced contrasting results. A decrease in population HIV-1 incidence was associated with improved STD case management in Mwanza; bu...
HIV

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind; randomised and placebo controlled trial

Lancet; 355 (9221), 2000
Infection with streptococcus pneumoniae is a frequent and serious problem for HIV-immunosuppressed adults. Vaccination is recommended in the USA and europe; but there are no prospective data that show vaccine efficacy. Methods: 1392 (937 female) HIV-1-infected adults in Entebbe; Uganda; were enrolled. 69...
HIV

Extent to which low-level use of antiretroviral treatment could cure the AIDS epidemic in sub-Saharan Africa

Lancet; 355 (9221), 2000
Despite growing international pressure to provide HIV-1 treatment to less-developed countries; potential demographic and epidemiological impacts have yet to be characterised. We modelled the future impact of antiretroviral use in south Africa from 2000 to 2005. methods: We produced a population projectio...
HIV

Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis

Setting: National Tuberculosis (TB) Treatment Centre; Mulago Hospital and Joint Clinical Research Centre; Kampala; Uganda. Objective: To compare the quantitative sputum bacillary load between TB patients infected with the human immunodeficiency virus (HIV) and those non-infected; during treatment with st...
HIV